Therapeutics News and Research

RSS
Cancer Research Technology and The Institute of Cancer Research complete licence with Vernalis

Cancer Research Technology and The Institute of Cancer Research complete licence with Vernalis

Phase II trials of the first second-generation antisense cancer drug to be used in patients soon to be underway

Phase II trials of the first second-generation antisense cancer drug to be used in patients soon to be underway

Trial shows which brain cancer patients benefit from temozolomide

Trial shows which brain cancer patients benefit from temozolomide

Researchers reveal potential new role for Glivec/Imatinib

Researchers reveal potential new role for Glivec/Imatinib

Arsenic trioxide - invented as a treatment for a rare type of leukaemia

Arsenic trioxide - invented as a treatment for a rare type of leukaemia

Guidant announces plans to initiate vulnerable plaque study

Guidant announces plans to initiate vulnerable plaque study

Stem cells from umbilical cord blood, given intravenously with mannitol drug reduce stroke size and damage

Stem cells from umbilical cord blood, given intravenously with mannitol drug reduce stroke size and damage

THC in marijuana may block the spread of forms of cancer causing herpes viruses

THC in marijuana may block the spread of forms of cancer causing herpes viruses

Breakthrough in spinal regeneration research

Breakthrough in spinal regeneration research

ChemGenex discovers five new depression genes

ChemGenex discovers five new depression genes

Genetically modified bacterium as remedy for intestinal diseases

Genetically modified bacterium as remedy for intestinal diseases

Potential new drug for the treatment of sickle cell disease

Potential new drug for the treatment of sickle cell disease

Transthyretin discovery may halt progression of Alzheimer's

Transthyretin discovery may halt progression of Alzheimer's

Scientist rewarded for breaking down transplant rejection

Scientist rewarded for breaking down transplant rejection

Advances in gene silencing on the agenda

Advances in gene silencing on the agenda

Exubera shows sustained blood glucose control in patients with type 2 diabetes

Exubera shows sustained blood glucose control in patients with type 2 diabetes

Phico Therapeutics secures funding to tackle superbug

Phico Therapeutics secures funding to tackle superbug

Chemotherapy experts refute ASCO recommendations on use of drug sensitivity and resistance assays

Chemotherapy experts refute ASCO recommendations on use of drug sensitivity and resistance assays

Gene - beta1-integrin, could be key to breast cancer therapies

Gene - beta1-integrin, could be key to breast cancer therapies

Study of new gene and cell therapy to better understand how genetically-engineered cells can help pace the heart

Study of new gene and cell therapy to better understand how genetically-engineered cells can help pace the heart

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.